Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases

Clinical Review Lesson of the week

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7407.147 (Published 17 July 2003) Cite this as: BMJ 2003;327:147

Cited by...

Pilot study to test the feasibility of a trial design and complex intervention on PRIoritising MUltimedication in Multimorbidity in general practices (PRIMUMpilot)
- Abstract
- Fulltext
- PDF
Survival after cardiopulmonary arrest with extreme hyperkalaemia and hypothermia in a patient with metformin-associated lactic acidosis
- Abstract
- Fulltext
- PDF
Beta-Blockers, Trimethoprim-Sulfamethoxazole, and the Risk of Hyperkalemia Requiring Hospitalization in the Elderly: A Nested Case-Control Study
- Abstract
- Fulltext
- PDF
Understanding the risk of hyperkalaemia in heart failure: role of aldosterone antagonism
- Abstract
- Fulltext
- PDF
Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker
- Abstract
- Fulltext
- PDF
Aldosterone antagonists in the treatment of heart failure
- Abstract
- Fulltext
- PDF
Adoption of Spironolactone Therapy for Older Patients With Heart Failure and Left Ventricular Systolic Dysfunction in the United States, 1998-2001
- Abstract
- Fulltext
- PDF
Life threatening hyperkalaemia with diarrhoea during ACE inhibition
- Abstract
- Fulltext
- PDF
Diabetes may be independent risk factor for hyperkalaemia
- Abstract
- Fulltext
- PDF